Let's Get Started

Healthcare

Clearmind Medicine Inc. (Nasdaq: CMND) Is Disrupting The Pharmaceutical Industry with a Revolutionary Treatment!

Clearmind Medicine Inc. (Nasdaq: CMND) Is Disrupting The Pharmaceutical Industry with a Revolutionary Treatment!

Jan 4, 2023

Clearmind Medicine CMND has consolidated from the latest amazing 252% run & indicators appear to reveal more explosive gains in the near future!

Now that it has created a base it appears ready for it’s next HUGE run, could it be 600%, 700%, 1,000%?!?!

Let’s take a quick look at the basics before digging into why CMND could be ready for it’s next big move!

Clearmind Medicine Company Summary

Company Name: Clearmind Medicine, Inc.

Ticker: CMND

Exchange: NASDAQ

Website: https://www.clearmindmedicine.com/

Clearmind Medicine Company Summary:

Clearmind Medicine Inc. (Nasdaq: CMND) is a psych-e-delic pharmaceutical biotech company focused on the discovery and development of novel psych-e-delic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder.

Its primary objective is to research and develop psych-e-delic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements.

The Company’s intellectual portfolio currently consists of seven patent families.

Clearmind Medicine Inc. (Nasdaq: CMND) intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind’s flagship treatments are focused on Alcohol Use Disorder(AUD), which is incredibly common. It varies from mild to excessive, and describes a person’s inability to restrict their alcohol consumption, despite negative social, occupational, or health consequences.

Clearmind Medicine Inc. Scores Milestone Patent 

Dec 27, 2022

Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) has taken a giant step forward in its mission to deliver a first-to-market psychedelic-based treatment targeting Alcohol Use Disorder (AUD). Last Wednesday, CMND announced being granted a patent from the United States Patent and Trademark Office (USPTO) to use its proprietary MEAI as an alcoholic beverage substitute. This allowance strengthens an already robust IP portfolio by adding to similar patents earned for its MEAI-based alcohol substitute in Europe and India.

The full article can be found HERE

Clearmind Medicine Inc.’s Psychedelic-Based Therapeutics Are Revolutionary To The Pharmaceutical Sector; Treating AUD In The Crosshairs ($CMND)

January 3rd, 2023

Driving that proposition is Clearmind Medicine nearing its goal of delivering a first-to-market psychedelic-based treatment to market, with its lead candidate, MEAI, targeting a $395BN alcohol-substitute product market.

“In pre-clinical trials, showed an ability to mitigate AUD Alcohol Use Disorder: a condition that encourages a vicious cycle of binge drinking by circumventing specific neural pathways that lead to sensible behavioral decisions. “

The full article can be found HERE

Clearmind Medicine Inc. Positions To Deliver A First-To-Market Psychedelic-Based Treatment For Alcohol Use Disorder

Dec 29, 2022

Thanks to a series of milestones reached, patents earned, and valuable partnerships, the company’s lead candidate, MEAI, may soon become the first-to-market psychedelic-based treatment targeting Alcohol Use Disorder (AUD). As an alcohol-substitute product, MEAI positions Clearmind to target a more than $395 million alcohol-substitute market opportunity and, more importantly, provide a product that could save millions of lives each year.

The full article can be found HERE

There is a massive market potential for Clearmind Medicine Inc. (Nasdaq: CMND). The company focuses on a huge untapped market with yearly economic impact costing the U.S. over $249 billion.(1)

Clearmind Medicine Inc. (Nasdaq: CMND) currently has 8 patents granted with 15 patent applications pending.(1) A patent can be an economic catalyst to pharmaceutical companies who push to research new and beneficial drugs on the premise that they will be able to reap rewards by way of profits.(2)

According to a national survey, 14.1 million adults ages 18 and older (5.6 percent of this age group) had AUD in 2019. (3)

Among youth, an estimated 414,000 adolescents ages 12–17 (1.7 percent of this age group) had AUD during this timeframe.(3)

What Increases the Risk for AUD? A person’s risk for developing AUD depends, in part, on how much, how often, and how quickly they consume alcohol. (3)

Alcohol misuse, which includes binge drinking and heavy alcohol use, over time increases the risk of AUD.(3)

Other factors also increase the risk of AUD, such as:

  • Drinking at an early age. A recent national survey found that among people ages 26 and older, those who began drinking before age 15 were more than 5 times as likely to report having AUD in the past year as those who waited until age 21 or later to begin drinking. The risk for females in this group is higher than that of males. (3)

  • Genetics and family history of alcohol problems. Genetics play a role, with heritability approximately 60 percent; however, like other chronic health conditions, AUD risk is influenced by the interplay between a person’s genes and their environment. Parents’ drinking patterns may also influence the likelihood that a child will one day develop AUD.(3)

  • Mental health conditions and a history of trauma. A wide range of psychiatric conditions—including depression, post-traumatic stress disorder, and attention deficit hyperactivity disorder—are comorbid with AUD and are associated with an increased risk of AUD. People with a history of childhood trauma are also vulnerable to AUD.(3)

Breaking the Cycle
Clearmind Medicine Inc. (Nasdaq: CMND) believes that MEAI breaks the vicious binge-drinking cycle at the decision point to drink more alcohol,by potentially innervating neural pathways such as 5-HT1A that lead to “sensible behavior.”(6)

Non-Addictive
Anecdotal reports and pre-clinical in-vivo results indicate on the self-limiting property of MEAI—unlike traditional treatments.(6)

Expansive Potential
The literature shows that 5-HT1A receptors are associated with controlling craving behavior across the board. This indicates that MEAI may have a wide range of applications beyond binge drinking.(6)

Successful preclinical results in MEAI treatment for alcohol consumption.(6)

Clearmind Medical is advancing its proprietary CMND-100, 5-methoxy-2-aminoindane-based treatment (MEAI), intending to provide relief to millions worldwide by using psychedelics to treat Alcohol Use Disorder (AUD).

The market potential from an approved CMND therapeutic can be enormous, replacing drugs and treatments that are sometimes more debilitating than the condition itself.

More importantly, CMND’s approach could mitigate patient resistance to treatment, opening the door to potentially billions in long-term revenues and saving thousands of lives per year. 

Biotech and Pharmaceutical stocks can offer tremendous upside potential when positive news is announced from Phase 1, Phase 2, and Phase 3 trials. Clearmind Medicine Inc. (Nasdaq: CMND) recently announced the initiation of a program to address its upcoming clinical trial.(4)

Clearmind Medicine Inc. recently announced the initiation of clinical batches of production of its novel psychedelic-derived drug candidate, the MEAI- based molecule- CMND-100.(4)

The produced batches will be used in the Company’s upcoming first in human (FIH) clinical trial evaluating the proprietary drug candidate compound CMND-100 for the treatment of Alcohol Use Disorder (AUD).

Following MEAI’s synthesis development process, the compound is being produced under GMP (Good Manufacturing Process) conditions to comply with FDA requirements.

The clinical batches production is made possible due to prior successful production of MEAI drug substance that was used in the Company’s pre- clinical studies designed to evaluate the safety of its innovative compound.

“Clearmind continues its progress toward FIH clinical trials,” said Dr. Adi Zuloff-Shani, Clearmind’s Chief Executive Officer.

“This milestone joins other achievements we’ve made in a relatively short period. Non-clinical data generated to date, demonstrate that our MEAI- based treatment has the potential to treat broad range of addictions and binge behaviors such as AUD.”(4)

“Like other addictions, AUD is a chronic relapsing brain disorder characterized by an impaired ability to stop or control alcohol use,” she added. (4)

“Alcohol abuse is the third most-common preventable cause of death in the United States, where almost 6% struggle with this condition.”(4)

The Company previously announced that it completed a highly constructive Pre-Investigational New Drug Application (“pre-IND”) meeting with the U.S. Food and Drug Administration (“FDA”) to discuss the development of CMND-100.

Clearmind Medicine Inc. (Nasdaq: CMND) has less than 1.2M shares available in its public float according to Finviz.(5) Low float stocks have the potential to present significant price swings if active market participants take notice.

Short squeeze?

If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme. Low float stocks can be some of the most volatile stocks in the market.

Clearmind Medicine CMND has consolidated from the latest amazing 252% run & indicators appear to reveal more explosive gains in the near future! Let’s review the 4 reasons you should put it on you watchlist NOW.

As a quick reminder of the 4 REASONS why you should pull up KAVL right now:

  1. Incredible Press Releases announcing their US Patent!

  2. Untapped Market Worth $249BN

  3. Clinical Trials on the horizon that could be worth Bill-ions

  4. Extremely Low Float – 1.2M shares is stupid LOW!

Source 1: https://www.clearmindmedicine.com/investors

Source 2: https://www.mckendree.edu/academics/scholars/issue11/bodem.htm

Source 3: https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/understanding-alcohol-use-disorder

Source 4: https://finance.yahoo.com/news/clearmind-announces-initiation-cmnd-100-134500937.html

Source 5: https://finviz.com/quote.ashx?t=CMND&p=d

Source 6: https://www.clearmindmedicine.com/investors

FULL DISCLAIMER

read more

Omega Therapeutics OMGA Stock Price is ready to take off? URGENT

Jul 6, 2022

Omega Therapeutics OMGA Stock Price has been trying to recover since it’s November high of almost $30.

Wondering why this stock is having such a hard time and if it can break the overall trend? Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!

<!-- TradingView Widget BEGIN -->
<div class="tradingview-widget-container">
  <div class="tradingview-widget-container__widget"></div>
  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/AAPL/" rel="noopener" target="_blank"><span class="blue-text">Apple</span></a> by TradingView</div>
  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-overview.js" async>
  {
  "symbols": [
    [
      "Apple",
      "AAPL|1D"
    ],
    [
      "Google",
      "GOOGL|1D"
    ],
    [
      "Microsoft",
      "MSFT|1D"
    ]
  ],
  "chartOnly": false,
  "width": 1000,
  "height": 500,
  "locale": "en",
  "colorTheme": "dark",
  "autosize": false,
  "showVolume": false,
  "showMA": false,
  "hideDateRanges": false,
  "hideMarketStatus": false,
  "hideSymbolLogo": false,
  "scalePosition": "right",
  "scaleMode": "Normal",
  "fontFamily": "-apple-system, BlinkMacSystemFont, Trebuchet MS, Roboto, Ubuntu, sans-serif",
  "fontSize": "10",
  "noTimeScale": false,
  "valuesTracking": "1",
  "changeMode": "price-and-percent",
  "chartType": "line"
}
  </script>
</div>
<!-- TradingView Widget END -->


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! OMGA Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis

Omega Therapeutics Company Information

Company Name: Omega Therapeutics Inc.

Ticker: OMGA

Exchange: NASDAQ

Website: https://omegatherapeutics.com/

Netlist Inc. Company Summary:

Omega Therapeutics, Inc. engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

OMGA stock price is due to News?

June 30, 2022 /

Announced the presentation of new preclinical data on its lead product candidate, OTX-2002, to regulate expression of the c-Myc (MYC) oncogene through epigenetic modulation in multiple models of hepatocellular carcinoma (HCC) in a poster presentation at the European Society of Medical Oncology (ESMO) 2022 World Congress on Gastrointestinal (GI) Cancer, taking place in Barcelona, Spain, June 29 – July 2, 2022.

OMGA 5 Day Chart

OMGA

OMGA Stock Price Technical Analysis:

I like it over $5 but the 1 day, 5 day and 10 day chart looks great! The news is wonderfule and volume is up!

I like the stock


[thrive_leads id=’14274′]

read more

NRSN Stock Price has consolidated and could be ready for a run? URGENT

Jun 28, 2022

NeuroSense Therapeutics Ltd. NRSN stock price is finally showing some life as it reverses trend. NRSN is up 55% in the last 5 days.

The volume is up over 140%, that is a great sign.

I will be evaluating many factors to determine just how HOT, the stock NSRN is.

The official HOT level for NRSN is, a 🔥🔥🔥 3 out of 5.

Continue reading to see why I think it is just a 3 out of 5. There is some shocking takeaways from this article that you must read if you are interested in SMCE.

If you are interested in finding out more about me, famed stock picker, Alexander Goldman or if you’re interested in my HOT grading system, sign up today, it’s FREE!

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇 In fact, I will send you personally a 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter.


[thrive_leads id=’14274′]

Before I go over this exciting trending stock, I wanted to introduce myself. Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading, at a very high level, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT grading system for trending stocks.

I found my home at Small Cap exclusive 4 years ago. Now, I’m helping traders find breakout stocks. Not to sound egotistical but I’m very good at finding small cap stocks that are winners.

What do I mean by big winners?

Stocks that move more than 100% in a month! NRSN Stock Price could?

Does that always happen, NO! But, I’m very consistent! Take a look at this article I wrote below, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE and I shine a spotlight on these breakout stocks and also those losers!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis and how I came up with HOT grade.

NeuroSense Therapeutics Ltd. Company Information

Company Name: NeuroSense Therapeutics Ltd.

Ticker: NRSN

Exchange: NASDAQ

Website: https://www.neurosense-tx.com/

Breakout Stock NeuroSense Therapeutics Ltd. Company Summary:

Neurosense Therapeutics Ltd. operates as a clinical stage drug development company. It offers ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. The company was founded by Alon Ben-Noon in February 2017 and is headquartered in Herzeliya, Israel.

NRSN stock price is due to News?

June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent treatment. Factors such as the increasing prevalence and incidence of pancreatic cancer and advancements in molecular biology, development of drugs, and diagnostic technology play a major part in market growth. With the increase in R&D initiatives, favorable reimbursement scenarios, and the launch of novel products, the market is expected to grow significantly during the forecast period. A report from Mordor Intelligence projected that the global pancreatic cancer therapeutics and diagnostics market, which was estimated to be USD 3,689.61 million in 2021 is expected to reach USD 5,656.58 million by 2027, registering a CAGR of 7.43% from 2022 to 2027. 

March 21, 2022 /PRNewswire via COMTEX/ — CAMBRIDGE, Mass., March 21, 2022 /PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.

PrimeC is a novel extended-release oral formulation composed of a unique fixed-dose combination of two FDA-approved drugs: ciprofloxacin and celecoxib. PrimeC is designed to synergistically target several key mechanisms of amyotrophic lateral sclerosis (ALS) that contribute to motor neuron degeneration, inflammation, iron accumulation and impaired RNA regulation to potentially inhibit the progression of ALS.

NSRN

NRSN Stock Price HOT Stock Grade:

The official heat level for NSRN is, a 🔥🔥 3 out of 5 . Continue reading to see why I think it is just a 3 out of 5. Here are my takeaways on NSRN and why it is just a 2 out of 5.

The volume, is the demand for a stock and this one is great! Up 140% over normal trading.

The news, is solid and the market has responded.

The chart, I like it, the chart is consolidated and appears to be ready to make another move.

The fundamentals, the vertical is a very profitable one!

Marketing efforts, I have not found a significant awareness campaign running. Furthermore, with news like this, there should be an effort to disseminate the important news to investors.

To receive my 🔥🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇


[thrive_leads id=’14274′]

read more

Change Healthcare CHNG Stock Price hit a 52 week high! What’s next? URGENT Report

Jun 21, 2022

Change Healthcare CHNG Stock Price just broke it’s 52 week high, can it go higher? Wondering why this stock is just broke it’s 52 week high??

Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! CHNG Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis

Change Healthcare Company Information

Company Name: Change Healthcare Inc.

Ticker: CHNG

Exchange: NASDAQ

Website: https://www.changehealthcare.com/

Change Healthcare Company Summary:

Our extensive network, innovative technology, and expertise inspire a stronger, better coordinated, increasingly collaborative, and more efficient healthcare system.

CHNG stock price is due to News?

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand our results of operations and financial condition. The MD&A is provided as a supplement to, and should be read in conjunction with, the Company’s audited financial statements and the accompanying notes.

CHNG 5 Day Chart

CHNG stock price

CHNG Stock Price Technical Analysis:

I like it a lot at $23.50 and possibly here but I love it if it can get back to $23.50


[thrive_leads id=’14274′]

read more

eExicure XCUR Stock Price is up, can it go higher? URGENT REPORT

Jun 13, 2022

eExicure XCUR stock price is down 5% in the last 5 days & volume is up 53%, but can it go up?

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for XCUR is, a 🔥2 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I established the coveted HOT Stock Reporting system.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Exicure Company Information

Company Name: Exicure Inc.

Ticker: XCUR

Exchange: NASDAQ

Website: https://www.exicuretx.com/

Exicure Company Summary:

Exicure,, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

XCUR stock price is due to News?

Director Bali Muralidhar acquired 1,472,126 shares of the business’s stock in a transaction on Thursday, May 19th. The stock was acquired at an average price of $0.19 per share, with a total value of $279,703.94. Following the acquisition, the director now owns 8,449,126 shares in the company, valued at approximately $1,605,333.94. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

XCUR

XCUR Stock Price HOT Stock Grade:

XCUR is, a 🔥🔥2 out of 4 . Here are my takeaways on it and why it is just a 2 out of 4.

XCUR Trading Volume

The volume, the normal trading volume is established by the previous 30 days of trading and this stock is trading at an increase of 53% over the average. Normally, this indicates a higher demand in the stock or a sell off (selling pressure).

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

XCUR Technicals

The technical analysis “chart reading”, this stock is down 15% on the 5 day chart and the overall trend for the long term chart, the 1 month, is down 35%. What can I say, the stock is a real loser!

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

XCUR News Cycle

The news, there is significant news, “nnounced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity (“PIPE”) financing.”

XCUR Fundamentals

The fundamentals, how a company is doing financially can be a serious KPI and there is no exciting financial filings associated with this stock. Down 102% now that is horrible!

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

XCUR Awareness

Marketing efforts “Awareness Campaigns” Just like advertising a product is important, advertising a publicly traded company during a news cycle is critical for the stock price of a company.

I have not found marketing efforts around the investor awareness of this company. So, I have awarded this stock a 2 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

APYX Stock Price is so consistent, can it go higher? URGENT

May 26, 2022

Apyx Medical APYX stock price is up 59% in the last 5 days & volume is up 12,881%, but is it over for this breakout stock?

There is an old adage, “two heads are better than one”, so let’s collaborate on APYX and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for APYX, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for APYX is, a 🔥🔥🔥 3 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Apyx Medical Company Information

Company Name: Apyx Medical

Ticker: APYX

Exchange: NASDAQ

Website: https://apyxmedical.com/

Apyx Medical Company Summary:

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

APYX stock price is due to News?

May 26th

Announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the use of the Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to severe wrinkles and rhytides, limited to patients with Fitzpatrick skin types I, II or III.

APYX

APYX Stock Price HOT Stock Grade:

The official heat level for APYX is, a 🔥🔥🔥 3 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. APYX is looking solid and I’m so excited for the next few days.

APYX Trading Volume

The volume, is trading at an increase of 12,000%++ over the average which indicates a significant higher demand in the stock which usually corelates into price increases when correlateed with positive news. You will see that in a moment!.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

APYX Technicals

The technical analysis “chart reading”, it is bullish and has a very nice steady chart associated with the fabulous news!

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

APYX News Cycle

The news, there is very significant news. Announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the use of the Renuvion Dermal Handpiece for specific dermal resurfacing procedures.

I can not stress how positive this news is, put it on your watchlist TODAY!

APYX Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “75% growth”! Yet again, very solid information circulating about this company!

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

APYX Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 3 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

NMXS Stock Price is up BIG, can it go higher? EXCLUSIVE Analysis

May 26, 2022

Net Medical Xpress Solutions NMXS stock price is up 11% in the last 5 days & volume is up 43%, but is it over for this breakout stock?

There is an old adage, “two heads are better than one”, so let’s collaborate on NMXS and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for NMXS, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for NMXS is, a 🔥1 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Net Medical Xpress Solutions Company Information

Company Name: Net Medical Xpress Solutions Inc.

Ticker: NMXS

Exchange: OTC

Website: https://www.welcome.netmedical.com/

Net Medical Xpress Solutions Company Summary:

Net Medical Xpress Solutions, Inc. engages in the provison of solutions for the telemedicine industry. It also offers a call center, hardware implementations, staffing and recruiting operations, diagnostic and clinical services, and research and development capabilities. The company was founded by Richard F. Govatski in 1995 and is headquartered in Albuquerque, NM.

NMXS stock price is due to News?

May 24, 2022 (ACCESSWIRE via COMTEX) — ALBUQUERQUE, NM / ACCESSWIRE / May 24, 2022 / Net Medical Xpress (OTC PINK:NMXS) announced today that it is preparing to launch a new testing service to support orthopedic surgeons in dealing with infection. CEO Dick Govatski said, “We are pleased to announce we are pairing with bioMérieux, a world leader in the field of in vitro diagnostics, to offer their new Joint Infection Panel to the orthopedic surgeon community.

May 04, 2022 (ACCESSWIRE via COMTEX) — ALBUQUERQUE, NM / ACCESSWIRE / May 4, 2022 / Net Medical Xpress (OTC PINK:NMXS) announced today unaudited revenue and net income for the first fiscal quarter ending March 31, 2022.

The company reported total revenue of $1,906,851. This compared with total revenue of $290,000 in the first quarter of 2021. Net income was $577,152 versus a loss of ($29,000) in the first quarter of 2021.

NMXS

NMXS Stock Price HOT Stock Grade:

The official heat level for NMXS is, a 🔥1 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

NMXS Trading Volume

The volume, is trading at an increase of almost 48% over the average which indicates a higher demand in the stock. The demand is noticeably different from earlier in the month when I wrote my last article on this stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

NMXS Technicals

The technical analysis “chart reading”, it is not looking solid in my opinion. It is a bearish overall trend!

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

NMXS News Cycle

The news, there is significant news: They are now profitable as you can see from the news release above! I love the tele-heath sector too.

NMXS Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “58% growth”!

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

NMXS Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 3 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

CTXR Stock Price is so consistent, can it go higher? URGENT

May 25, 2022

Citius Pharmaceuticals CTXR stock price is down 2% in the last 5 days & volume is up 48%, but is it over for this breakout stock?

There is an old adage, “two heads are better than one”, so let’s collaborate on CTXR and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for CTXR, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for CTXR is, a 🔥🔥🔥 3 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Citius Pharmaceuticals Company Information

Company Name: Citius Pharmaceuticals

Ticker: CTXR

Exchange: NASDAQ

Website: https://citiuspharma.com/home/default.aspx

Citius Pharmaceuticals Trust Company Summary:

Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to people suffering from hemorrhoids, NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome, and I/ONTAK, a protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL). The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

CTXR stock price is due to News?

May 25, 2022

Announced that it intends to split the Company’s assets into two separate publicly-traded entities. Citius plans to form a new company (NewCo) focused on developing and commercializing I/ONTAK, for which a Phase 3 trial was completed in December 2021 and a biologics license application (BLA) is being planned for submission in the second half of 2022. The Company’s other pipeline assets, including Mino-Lok(R), would remain at Citius. Citius would continue to trade on the Nasdaq exchange under its current ticker CTXR. The strategic action is intended to optimize organizational resources and investment capital to support the successful execution of each development program.

CTXR

CTXR Stock Price HOT Stock Grade:

The official heat level for CTXR is, a 🔥🔥🔥 3 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

CTXR Trading Volume

The volume, is trading at an increase of 48% over the average which indicates a higher demand in the stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

CTXR Technicals

The technical analysis “chart reading”, it is bullish and has been that way since the early part of this month with a steady ascending channel.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

CTXR News Cycle

The news, there is no significant news.

CTXR Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “265% growth”!

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

CTXR Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 3 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

TC BioPharm TCBP Stock Price broke out, the set up is AMAZING! Pay ATTENTION!

May 17, 2022

TC BioPharm TCBP stock price is up today & volume is up 8%, this appears to be the bottom I have been waiting for. I am consequently, placing an immediate and elusive 4🔥 official heat level for TC BioPharm TCBP is, that is a 🔥🔥🔥 4 out of 4!

There is an old adage, “two heads are better than one”, so let’s collaborate on TCBP and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for TCBP, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for TCBP is, a 🔥🔥🔥🔥 4 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

TC BioPharm Company Information

Company Name: TC BioPharm Inc.

Ticker: TCBP

Exchange: NASDAQ

Website: https://www.tcbiopharm.com/

TC BioPharm Company Summary:

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.

TCBP stock price is due to News?

April 6, 2022

Announced that it has successfully registered the UK trademark “CryoTC®”, for the Company’s proprietary process for freezing and thawing of its lead oncology product, OmnImmune®.

CryoTR® is TC BioPharm’s unique process of cryopreservation, which is performed in a controlled rate freezer using an optimized protocol. OmnImmune® is an allogeneic unmodified cell therapy consisting of activated and expanded gamma delta T cells. OmnImmune® comprises GDT cells sourced from healthy donors, activated and expanded in large numbers before being purified formulated, and cryopreserved for subsequent thawing and infusion into patients. 

TCBP stock Price

TCBP Stock Price HOT Stock Grade:

The official heat level for ECTM is, a 🔥🔥🔥🔥 4 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

TCBP Trading Volume

The volume, is trading at an increase of 8% over the average which indicates a higher demand in the stock. This is a great sign that trading activity is picking up, but we also don’t want to see 100%, 200% or even 400% increases in volume because that would mean the short term move is over.

I pride myself in determining moves before they happen! I believe, this may be the very situation wee are witnessing right now with TC BioPharm NASDAQ:TCBP. Pay attention!

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

TCBP Technicals

The technical analysis “chart reading”, it is consolidated after a bearish move and now has broken out of the consolidation as you can see from the chart below.

TCBP

That tap at $1.00 was significant as well as the resistance point at $.95 that was broken and is holding. Hence I am placing TCBP on an immediate 4 out 4 alert!

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

TCBP News Cycle

The news, there is significant news. The news, “Announced that it has successfully registered the UK trademark “CryoTC®”, for the Company’s proprietary process for freezing and thawing of its lead oncology product, OmnImmune®.” is huge! Cancer will be a $268 BILLION dollar industry by 2026. HERE

TCBP Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “265% growth”!

As you can see from the above screen shot from Market Watch HERE

The EBITDA has grown at 18%, that is STRONG!

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

TCBP Awareness

Marketing efforts “Awareness Campaigns”, I have found marketing efforts around the investor awareness of this company. Hence the 4 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

Small Cap Exclusive is owned and operated by JBN PARTNERS LLC, which is a US based corporation. We have been compensated $4,000 for profiling TCBP. We own ZERO shares in TCBP. We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).

Full Disclaimer

read more